Results

Total Results: 2,279 records

Showing results for "factor".

101. Maternal Morbidity and Mortality | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/maternal-morbidity-mortality/protocol
     December 01, 2022 - , People of Color (BIPOC) individuals. 13 Important to recognize is that race itself is not a risk factor … We will use the ROBINS-E tool, which is designed specifically to address risk factor research. 32 , … when 1) at least two studies with sufficiently similar designs and populations examined the same risk factor … identify people followed in a study to help understand who may be similarly be subject to the risk factor … or hazard model* or logistic regression or "near miss").ti,ab,kw.    775160 (risk* adj3 (assess* or factor

102. Maternal Morbidity and Mortality (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
     February 02, 2022 - Indigenous, People of Color (BIPOC) individuals.13 Important to recognize is that race itself is not a risk factor … We will use the ROBINS-E tool, which is designed specifically to address risk factor research.32, 33 … when 1) at least two studies with sufficiently similar designs and populations examined the same risk factor … identify people followed in a study to help understand who may be similarly be subject to the risk factor … or logistic regression or "near miss").ti,ab,kw. 775160 10 (risk* adj3 (assess* or factor

103. Chapter 6: Assessing Applicability of Medical Test Studies in Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-applicability/methods
     December 01, 2019 - Decisions should be based on whether there is evidence that a particular contextual factor is expected … assessing the accuracy of cardiac MRI for detecting atherosclerosis, slice thickness is a relevant factor … Care Over Time Routine use of a medical test as a screening test might be considered an indirect factor … In some cases, failing to consider a particular factor may have been an oversight; in retrospect, the … importance of that factor on the applicability of test results may be physiologically sensible and supported

104. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - : affects five or more joints during the first 6 months of disease; is subclassified as rheumatoid factor-negative … and rheumatoid factor-positive disease, the latter of which may be associated with more destructive … nephrotoxicity; hepatotoxicity D-Penicillamine Depen Cuprimine Unknown (may lower IgM rheumatoid factor … sensitivity analyses include: study quality, including the quality of the measurement of exposure to the factor … Settings RCTs Randomized Controlled Trials TEP Technical Expert Panel TNF Tumor Necrosis Factor

105. Breast Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/breast-cancer
     January 31, 2023 - to the 2009 Report Research Report September 13, 2012 Data Points #15: Prognostic factor

106. Evaluation and Treatment of Tinnitus: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/tinnitus/research-protocol
     December 01, 2019 - ) * b) study controls for any additional factor * (This criteria could be modified to indicate … specific control for a second important factor.) … ) * b) study controls for any additional factor * (This criteria could be modified to indicate … The prognostic factor measure and method are adequately valid and reliable to limit misclassification … Appropriate methods are used if imputation is used for missing prognostic factor

107. Bleeding | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/bleeding
     June 22, 2017 - October 29, 2010 Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor

108. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-afib-update/research-protocol
     September 01, 2019 - patients with a score ≥2, and it should be considered for patients with a score of 1 (i.e., with one risk factor … patients with non-valvular AF: dabigatran (thrombin inhibitor), apixaban, rivaroxaban, and edoxaban (all factor … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … thrombin inhibitors"[tiab] OR antithrombin[tiab] OR antithrombins[tiab] OR antithrombotic[tiab] OR "factor … Xa inhibitor"[tiab] OR "factor Xa inhibitors"[tiab] OR "Blood clotting inhibitor"[tiab] OR "blood clotting

109. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - Rivaroxaban was included; it is an oral factor Xa inhibitor that the FDA approved in July 2011 for … direct thrombin inhibitors) • IVC filters • Mechanical devices • Pharmacologic (UFH LMWHs, factor … Xa inhibitors, direct thrombin inhibitors) • Pharmacologic (UFH, LMWHs, factor Xa inhibitors, … direct thrombin inhibitors) • Mechanical devices IVC filters • Pharmacologic (UFH LMWHs, factor … studies, studies that used active controls, and uncontrolled studies • Low-dose UFH, LMWHs, factor

110. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
     July 01, 2012 - Decisions should be based on whether there is evidence that a particular contextual factor is expected … assessing the accuracy of cardiac MRI for detecting atherosclerosis, slice thickness is a relevant factor … Preventive Care Over Time Routine use of a medical test as a screening test might be considered an indirect factor … In some cases, failing to consider a particular factor may have been an oversight; in retrospect, the … importance of that factor on the applicability of test results may be physiologically sensible and

111. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
     January 10, 2012 - and Specificity"/ or "Reproducibility of Results"/ or "Severity of Illness Index"/ or (risk adj2 (factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Results") S13 (MH "ROC Curve") S14 S7 or S8 or S9 or S10 or S11 or S12 or S13 S15 "risk factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor

112. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
     October 01, 2015 - tyrosine kinase inhibitor that targets the intracellular signaling of multiple proangiogenic growth factor … receptors purportedly involved in the pathogenesis of IPF, including vascular endothelial growth factor … receptor 2 (VEGFR2), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor … receptor kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), fibroblast growth … factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR).

113. Pharmacological Management of Crohn's Disease: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/crohns-disease-future/research
     December 01, 2019 - The first biologic tumor necrosis factor (TNF)-alpha inhibitor, infliximab, was approved by the Food

114. Immune System and Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders?page=2
     May 02, 2011 - Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor

115. Liver Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/liver-diseases
     October 23, 2014 - Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

116. Interventions for Preventing Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cognitive-decline/research-protocol
     December 01, 2020 - addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … The etiology may involve more than one risk factor and interventions may have several components. … interventions for preventing dementia have looked at only the one-to-one relationship with a single risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor

117. Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/multiple-sclerosis/research
     December 01, 2019 - who were considering pregnancy or already pregnant or patients discontinuing natalizumab due to risk factor

118. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Oxytocin factor - 30 ml nasal spray. [internet]. Amazon.com, Inc. … Available: http://www.amazon.com/Oxytocin- Factor-30-Nasal-Spray/dp/B007K8LTD2. 30. … Oxytocin factor. [internet]. ABC Nutriceuticals [accessed 2013 Nov 21]. [2 p]. … startswith=oxytocin&x=0&y=0 http://www.fda.gov/ http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/ … dp/B007K8LTD2 http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/dp/B007K8LTD2 http://tryoxytoday.com

119. Management of Postpartum Hemorrhage | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hemorrhage-postpartum/research
     December 01, 2019 - Studies suggested an association between recombinant activated factor VIIa and thromboembolic events,

120. PowerPoint Presentation (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Example: Slice thickness is a relevant factor for assessing the applicability/accuracy of cardiac magnetic … Principle 1: Identify Important Contextual Factors (2 of 10) The first contextual factor is spectrum … Principle 1: Identify Important Contextual Factors (3 of 10) The second contextual factor concerns where … Principle 1: Identify Important Contextual Factors (4 of 10) The third contextual factor concerns the … Principle 1: Identify Important Contextual Factors (9 of 10) The sixth and final contextual factor to